Curing blindness with regenerative cell therapies
StemSight develops off-the-shelf cell therapies for unmet medical needs in corneal blindness.
EIT Health Catapult Biotech pitching competition 2022-2023
Tech Tour's flagship event for Europe's most innovative companies
"The most innovative startup in health and life sciences in Europe"
2020
Latest news
13/02/2023
EIT Health Catapult Semifinals pitches online!
The Biotech category semifinalist pitches are now live on the EIT Health Catapult platform on-demand. Register here for free to see all the pitches. The finalists will be announced later in the Spring, and the top companies will present live at the Bits and Pretzels Healthtech event in Munich in June.
15/06/2022
StemSight wins in the Silicon Vikings Finland pitching competition finals
StemSight has been selected as the winner from Finland in the Silicon Vikings New Nordics pitching competition. The Nordic and Baltic finalists will compete against each other in the Grand Finals during Slush Week in November.
05/10/2022
Laura Koivusalo one of the Ten Outstanding Young Persons of the World
The global Junior Chamber International organization selects StemSight CEO Laura among this year's Ten Outstanding Young Persons of the World. Amazing news!
10/06/2022
StemSight a semifinalist in EIT Health Catapult programme
StemSight has been selected among the 14 European Biotech startups selected to compete in the semifinals of EIT Health's Catapult programme. Each year, the competition showcases Europe’s most promising biotech, medtech and digital health start-ups to leading experts and investors.
